![Stephen Glover](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Glover
Directeur Général chez
ZYVERSA THERAPEUTICS, INC.
Fortune : 69 759 $ au 30/06/2026
Profil
Stephen C.
Glover is the founder of ZyVersa Therapeutics Operating, Inc., founded in 2014, holding the title of Chairman & Chief Executive Officer.
Mr. Glover was the founder of Coherus Oncology, Inc., founded in 2010, holding the title of Chief Business Officer from 2010 to 2013.
Mr. Glover is the founder of ZyVersa Therapeutics, Inc., founded in 2014, holding the title of Chairman, President & Chief Executive Officer since 2022.
Mr. Glover is also the founder of Asclepius Life Sciences Fund LP..
Mr. Glover is currently Chairman at PDS Biotechnology Corp.
since 2019.
Mr. Glover is currently Director at Wallace H.
Coulter Foundation.
Mr. Glover is currently Director at Biogene Therapeutics, Inc. Mr. Glover is currently Director at Asclepius Life Sciences Fund LP.
Mr. Glover is currently Director at Inflamacore LLC.
Mr. Glover is currently Director at Two B Pharma.
Mr. Glover is currently Director at Oncolytics Biotech, Inc. starting in 2026.
Former positions include Chairman at Ambrx Biopharma Cayman, Inc. from 2023 to 2024.
Chairman at Ambrx, Inc. Chairman at PDS Operating Corp.
Director at INCON Co., Ltd. Director at Auriga Laboratories, Inc. Senior Vice President-Brand Operations at Andrx Corp.
from 2003 to 2006.
President at Insmed Therapeutic Proteins from 2007 to 2009.
Chief Business Officer & Executive Vice President at Insmed, Inc. from 2007 to 2010.
Senior Vice President & General Manager at Andrx Laboratories, Inc. Senior Vice President & General Manager at Watson Therapeutics, Inc. Principal at Amgen, Inc. Principal at IQVIA, Inc. Chief Business Officer at InteKrin Therapeutics, Inc. Principal at Hoffmann-La Roche, Inc. Education includes undergraduate degree(s) from Illinois State University, with a degree conferred in 1982.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PDS BIOTECHNOLOGY CORP. 0,14 % | 15/06/2026 | 78 851 ( 0,14 % ) | 69 468 $ | 30/06/2026 |
| 11/07/2025 | 1 819 ( 0,02 % ) | 291 $ | 30/06/2026 | |
| 01/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Stephen Glover
| Sociétés | Poste | Début |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Président | - |
| ZYVERSA THERAPEUTICS, INC. | Directeur Général | 01/12/2022 |
| ONCOLYTICS BIOTECH INC. | Directeur/Membre du Conseil | 01/06/2026 |
Wallace H. Coulter Foundation
 Wallace H. Coulter Foundation Miscellaneous Commercial ServicesCommercial Services Foundation | Directeur/Membre du Conseil | - |
Two B Pharma
 Two B Pharma Pharmaceuticals: GenericHealth Technology Operates as a clinical-stage pharmaceutical company which develops drugs | Directeur/Membre du Conseil | - |
Inflamacore LLC | Directeur/Membre du Conseil | - |
Asclepius Life Sciences Fund LP
 Asclepius Life Sciences Fund LP Financial ConglomeratesFinance Provides pooled investment funds | Directeur/Membre du Conseil | - |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur Général | 01/03/2014 |
Anciens postes connus de Stephen Glover
| Sociétés | Poste | Fin |
|---|---|---|
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Président | 07/03/2024 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Stephen Glover
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Andrx Corp.
 Andrx Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral pharmaceuticals products | Health Technology |
IQVIA, Inc.
 IQVIA, Inc. Packaged SoftwareTechnology Services Provides AI assistant, analytics and clinical research services for healthcare sector | Technology Services |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
PDS Operating Corp.
 PDS Operating Corp. Pharmaceuticals: MajorHealth Technology Develops novel cancer immunotherapies and vaccines for infectious disease | Health Technology |
ZyVersa Therapeutics Operating, Inc.
ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Wallace H. Coulter Foundation
Wallace H. Coulter Foundation Miscellaneous Commercial ServicesCommercial Services Foundation | Commercial Services |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Illinois State University
 Illinois State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
INCON Co., Ltd.
 INCON Co., Ltd. Electronics/AppliancesConsumer Durables Manufactures and sells digital video recorders | Consumer Durables |
Auriga Laboratories, Inc.
 Auriga Laboratories, Inc. BiotechnologyHealth Technology Engages in the commercialization, licensing and development of prescription pharmaceutical products | Health Technology |
Andrx Laboratories, Inc.
 Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactured specialty pharmaceuticals | Health Technology |
Insmed Therapeutic Proteins | |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Watson Therapeutics, Inc. | |
PDS Biotechnology Corp.
 PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
Asclepius Life Sciences Fund LP
Asclepius Life Sciences Fund LP Financial ConglomeratesFinance Provides pooled investment funds | Finance |
Inflamacore LLC | |
Two B Pharma
Two B Pharma Pharmaceuticals: GenericHealth Technology Operates as a clinical-stage pharmaceutical company which develops drugs | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Health Technology |
ZyVersa Therapeutics, Inc.
 ZyVersa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops product candidates in the areas of renal and inflammatory diseases | Health Technology |
